… Lung cancer is often diagnosed at an advanced stage, rendering the disease intractable.
Lung cancer can be broadly categorized into non-small-cell … stage small-cell lung cancer (ED …

… lung cancer are tobacco smoking-related and (b) only a proportion of lifelong smokers will
develop COPD and/or squamous cell … smoking-related COPD and squamous cell carcinoma. …

… This review covers the roles of immune cells in the tumor microenvironment in general and
in the non-small cell lung cancer (NSCLC) microenvironment in particular. The possibility of …

… in some patients with non-small-cell lung cancer (NSCLC). These effects are … cell growth,
differentiation, or apoptosis (programmed cell death). When certain retinoid receptors in the cell …

… The frequent recurrence of early-stage non-small-cell lung cancer (NSCLC) is generally …
We aimed to develop and validate a practical, reliable assay that improves risk stratification …

… lung cancer histological cell type gene marker sets were associated with lung development
… in the two temporally associated lung development groups previously identified by self-…

… 80% of overall lung cancer cases … develop and validate a simple prognostic index for 4-year
mortality in patients with NSCLC by use of information obtained at the time of lung cancer …

… Although these data only deal with benefits before lung cancer development, smoking
cessation after diagnosis increases survival by months, which is an improvement on the outcomes …

… in normal lung growth, especially in Clara cell precursors. Non-small cell lung cancers,
including … of the Notch pathway is a potential experimental approach to lung cancer treatment. …

… [4,5,6,7,8,9,10] Indeed, the changing landscape of lung cancer therapy was heralded … lung
cancer are summarized in Figure 1. This article delineates the rationale for the development …